Specifically, melanoma cells bearing the most common oncogenic mutation BRAFV600E rely, at least partly, on the activity of the dual-specificity phosphatase DUSP6/MKP3, a negative feedback regulator of ERK signaling, to keep the ERK activity within the optimal range (3). This evidence concerns the gene MAPK1 and melanoma.